The American Academy of Ophthalmology’s new Intelligent Research in Sight (IRIS™) eye disease clinical registry, which launches nationwide in early 2014, will allow the collection and analysis of patient data.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
In this video, Bill Rich, MD, the academy’s Medical Director of Health Policy, explains how the IRIS™ registry works, and how it will benefit ophthalmologists and their patients by tracking outcomes and improving quality of care.